NO20060257L - Procedures for the diagnosis and prognosis of Alzheimer's disease - Google Patents
Procedures for the diagnosis and prognosis of Alzheimer's diseaseInfo
- Publication number
- NO20060257L NO20060257L NO20060257A NO20060257A NO20060257L NO 20060257 L NO20060257 L NO 20060257L NO 20060257 A NO20060257 A NO 20060257A NO 20060257 A NO20060257 A NO 20060257A NO 20060257 L NO20060257 L NO 20060257L
- Authority
- NO
- Norway
- Prior art keywords
- disease
- alzheimer
- prognosis
- diagnosis
- procedures
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 238000004393 prognosis Methods 0.000 title abstract 2
- 101150033922 ABCA2 gene Proteins 0.000 abstract 2
- 108700028369 Alleles Proteins 0.000 abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Neurosurgery (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Det beskrives metoder for diagnose eller prognose av Alzheimers sykdom hos et individ. Denne fremgangsmåte har minst ett trinn for detektering av nærværet eller fiiaværet av minoritærallelen av polymorfismen rs908832 av genet ABCA2. Nærværet av denne minoritetsallel av polymorfismen rs908832 av genet ABCA2 indikerer at individet kan få Alzheimers sykdom eller har en øket risiko for å utvikle Alzheimers sykdom.Methods for the diagnosis or prognosis of Alzheimer's disease are described in an individual. This method has at least one step for detecting the presence or absence of the minority allele of polymorphism rs908832 of the ABCA2 gene. The presence of this minority allele of the polymorphism rs908832 of the ABCA2 gene indicates that the individual may have Alzheimer's disease or be at increased risk of developing Alzheimer's disease.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0307501A FR2856409B1 (en) | 2003-06-20 | 2003-06-20 | METHODS OF DETECTING ALZHEIMER'S DISEASE |
| PCT/FR2004/001509 WO2004113568A2 (en) | 2003-06-20 | 2004-06-17 | Methods for the diagnosis and prognosis of alzheimer's disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20060257L true NO20060257L (en) | 2006-01-18 |
Family
ID=33484616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20060257A NO20060257L (en) | 2003-06-20 | 2006-01-18 | Procedures for the diagnosis and prognosis of Alzheimer's disease |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1639139B1 (en) |
| JP (1) | JP4691491B2 (en) |
| KR (1) | KR101170651B1 (en) |
| CN (1) | CN1809645B (en) |
| AR (1) | AR044492A1 (en) |
| AT (1) | ATE518005T1 (en) |
| AU (1) | AU2004249919B2 (en) |
| BR (1) | BRPI0411658A (en) |
| CA (1) | CA2529633C (en) |
| CY (1) | CY1111970T1 (en) |
| DK (1) | DK1639139T3 (en) |
| ES (1) | ES2370491T3 (en) |
| FR (1) | FR2856409B1 (en) |
| HR (1) | HRP20110778T1 (en) |
| IL (1) | IL172690A0 (en) |
| MX (1) | MXPA05012800A (en) |
| NO (1) | NO20060257L (en) |
| PL (1) | PL1639139T3 (en) |
| PT (1) | PT1639139E (en) |
| RU (2) | RU2380423C2 (en) |
| SI (1) | SI1639139T1 (en) |
| TW (1) | TWI352738B (en) |
| WO (1) | WO2004113568A2 (en) |
| ZA (1) | ZA200509945B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2315559C1 (en) * | 2006-10-13 | 2008-01-27 | Иван Васильевич Максимович | Method of complex ray diagnostics of pre-clinic and clinic stages of alzheimer disease |
| CN103013989A (en) * | 2011-09-23 | 2013-04-03 | 深圳北京大学香港科技大学医学中心 | Single-nucleotide polymorphisms of cyclin dependent kinase 5 related to senile dementia incidence |
| GB201212084D0 (en) * | 2012-07-06 | 2012-08-22 | Randox Lab Ltd | Tropomyosin isoforms related to alzheimers disease and mild cognitive impairment |
| CN102768189B (en) * | 2012-07-30 | 2014-11-19 | 黄石 | Method for screening drugs |
| CN104313144B (en) * | 2014-10-16 | 2017-02-01 | 卫生部北京医院 | Reagent for detecting susceptibility of Alzheimer's disease |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5853995A (en) * | 1997-01-07 | 1998-12-29 | Research Development Foundation | Large scale genotyping of diseases and a diagnostic test for spinocerebellar ataxia type 6 |
| JP2003509017A (en) * | 1999-08-20 | 2003-03-11 | アクティブ パス ファーマシューティカルズ， インコーポレイテッド | Human ABC2 transporter and uses thereof |
| AU2001276995C1 (en) * | 2000-07-20 | 2006-10-26 | Cephalon, Inc. | Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring |
| JP2004147502A (en) * | 2000-07-26 | 2004-05-27 | Banyu Pharmaceut Co Ltd | Human and rat ABCA2 genes |
| WO2002064781A2 (en) * | 2001-02-09 | 2002-08-22 | Active Pass Pharmaceuticals, Inc. | Regulation of amyloid precursor protein expression by modification of abc transporter expression or activity |
| JP2004538450A (en) * | 2001-06-08 | 2004-12-24 | ゼノン ジェネティクス，インコーポレイテッド | Treatment of nervous system disorders and reproductive organ disorders |
-
2003
- 2003-06-20 FR FR0307501A patent/FR2856409B1/en not_active Expired - Fee Related
-
2004
- 2004-06-09 AR ARP040101994A patent/AR044492A1/en active IP Right Grant
- 2004-06-17 WO PCT/FR2004/001509 patent/WO2004113568A2/en not_active Ceased
- 2004-06-17 CN CN2004800172750A patent/CN1809645B/en not_active Expired - Fee Related
- 2004-06-17 BR BRPI0411658-5A patent/BRPI0411658A/en not_active IP Right Cessation
- 2004-06-17 JP JP2006516300A patent/JP4691491B2/en not_active Expired - Fee Related
- 2004-06-17 KR KR1020057024490A patent/KR101170651B1/en not_active Expired - Fee Related
- 2004-06-17 DK DK04767370.2T patent/DK1639139T3/en active
- 2004-06-17 PT PT04767370T patent/PT1639139E/en unknown
- 2004-06-17 MX MXPA05012800A patent/MXPA05012800A/en active IP Right Grant
- 2004-06-17 AT AT04767370T patent/ATE518005T1/en active
- 2004-06-17 RU RU2006101561/13A patent/RU2380423C2/en not_active IP Right Cessation
- 2004-06-17 EP EP04767370A patent/EP1639139B1/en not_active Expired - Lifetime
- 2004-06-17 RU RU2009104533/10A patent/RU2483108C2/en not_active IP Right Cessation
- 2004-06-17 PL PL04767370T patent/PL1639139T3/en unknown
- 2004-06-17 SI SI200431759T patent/SI1639139T1/en unknown
- 2004-06-17 ES ES04767370T patent/ES2370491T3/en not_active Expired - Lifetime
- 2004-06-17 CA CA2529633A patent/CA2529633C/en not_active Expired - Fee Related
- 2004-06-17 HR HR20110778T patent/HRP20110778T1/en unknown
- 2004-06-17 AU AU2004249919A patent/AU2004249919B2/en not_active Ceased
- 2004-06-18 TW TW093117572A patent/TWI352738B/en not_active IP Right Cessation
-
2005
- 2005-12-07 ZA ZA200509945A patent/ZA200509945B/en unknown
- 2005-12-19 IL IL172690A patent/IL172690A0/en not_active IP Right Cessation
-
2006
- 2006-01-18 NO NO20060257A patent/NO20060257L/en not_active Application Discontinuation
-
2011
- 2011-10-27 CY CY20111101024T patent/CY1111970T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Guo et al. | Three-stage quality control strategies for DNA re-sequencing data | |
| Cuyvers et al. | Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond | |
| Drew et al. | Improved inherited peripheral neuropathy genetic diagnosis by whole‐exome sequencing | |
| Guo et al. | Very low-level heteroplasmy mtDNA variations are inherited in humans | |
| Sassi et al. | Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer's disease | |
| Donner et al. | Exome sequencing reveals three novel candidate predisposition genes for diffuse gastric cancer | |
| Wong et al. | The genetic diversity of cystinuria in a UK population of patients | |
| Maia et al. | Identification of two novel HOXB13 germline mutations in Portuguese prostate cancer patients | |
| Liu et al. | Genome-wide linkage, exome sequencing and functional analyses identify ABCB6 as the pathogenic gene of dyschromatosis universalis hereditaria | |
| Chung et al. | A novel mutation of TMPRSS3 related to milder auditory phenotype in Korean postlingual deafness: a possible future implication for a personalized auditory rehabilitation | |
| Meyer et al. | Association between brown eye colour in rs12913832: GG individuals and SNPs in TYR, TYRP1, and SLC24A4 | |
| Krawitz et al. | Screening for single nucleotide variants, small indels and exon deletions with a next‐generation sequencing based gene panel approach for U sher syndrome | |
| Kim et al. | Genetic analysis of genes related to tight junction function in the Korean population with non-syndromic hearing loss | |
| WO2012031207A3 (en) | Methods and compositions for correlating genetic markers with prostate cancer risk | |
| Nguyen-Dumont et al. | Genetic testing in Poland and Ukraine: should comprehensive germline testing of BRCA1 and BRCA2 be recommended for women with breast and ovarian cancer? | |
| WO2020231081A1 (en) | Top3b gene mutation-based dementia diagnosis method | |
| Anderson et al. | The challenges of chromosome Y analysis and the implications for chronic kidney disease | |
| WO2017218798A1 (en) | Systems and methods for diagnosing familial hypercholesterolemia | |
| Jelsig et al. | Whole genome sequencing and disease pattern in patients with juvenile polyposis syndrome: a nationwide study | |
| WO2004058051A3 (en) | Androgen-regulated genes and uses for diagnosis, prognosis and treatment of prostate neoplastic conditions | |
| Cesca et al. | A novel mutation of the EYA4 gene associated with post-lingual hearing loss in a proband is co-segregating with a novel PAX3 mutation in two congenitally deaf family members | |
| Markocsy et al. | Complex analysis of the national Hereditary angioedema cohort in Slovakia–Identification of 12 novel variants in SERPING1 gene | |
| Wolf et al. | Efficiency of the revised Bethesda guidelines (2003) for the detection of mutations in mismatch repair genes in Austrian HNPCC patients | |
| WO2007086980A3 (en) | Methods of determining the risk of developing coronary artery disease | |
| CY1111970T1 (en) | METHODS FOR DETECTION OF ALTSCHEIMER DISEASE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |